Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 16,278 shares at $1.01 ($16K) on 2024-11-19, disclosed to the SEC on 2024-11-20.
Tax-driven sale ($16k) by President & CEO — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |